Metraipolis › archive › dc_de6e44932eda

Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris-A Case Report — Europe PMC PMID:41098197

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41098197
DOI
10.1002/ccr3.71232
License (as archived)
solo-consultazione
Archived
2026-11-09T08:30:47.127Z
SHA-256 of the archived text
2a9e1deab43462122e44f9aadb8d45b31a17bdb326ebfe283611608a827a2e88
Stable URL of this page
https://metraipolis.com/documento/dc_de6e44932eda

How to cite

Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris-A Case Report — Europe PMC PMID:41098197 — Europe PMC (en), https://europepmc.org/article/MED/41098197 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de6e44932eda (Metraipolis archive dc_de6e44932eda, sha256 2a9e1deab43462122e44f9aadb8d45b31a17bdb326ebfe283611608a827a2e88)
BibTeX
@misc{dcde6e44932eda,
  title = {Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris-A Case Report — Europe PMC PMID:41098197},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41098197},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de6e44932eda; sha256 2a9e1deab43462122e44f9aadb8d45b31a17bdb326ebfe283611608a827a2e88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41098197. Agents can read the archived copy with the MCP tool read_document.